SCHEMBL2085063

SCHEMBL2085063

CC(C)Cc1cccnc1C=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.42
GABRB2 P47870 2/20 0.42
TRIM24 O15164 1/20 0.36
TRIM33 Q9UPN9 1/20 0.36
MAPK1 P28482 1/20 0.36
CTSS P25774 1/20 0.35
CTSK P43235 1/20 0.35
KDM4E B2RXH2 2/20 0.34
CYP1A2 P05177 3/20 0.33
ALDH1A1 P00352 2/20 0.33
CYP2C19 P33261 2/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C8 P10632 1/20 0.33
CYP2C9 P11712 1/20 0.33
MAPT P10636 1/20 0.33
ALOX5AP P20292 1/20 0.32
FEN1 P39748 1/20 0.32
TKT P29401 1/20 0.32
PGR P06401 1/20 0.32
ADORA3 P0DMS8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4031836 0.83 NPSR1 (0.34) TRIM24TRIM33KDM4ECYP1A2ALDH1A1
SCHEMBL6115316 0.82 TRIM24 (0.39) GABRA1GABRB2TRIM24TRIM33KDM4E
SCHEMBL4030524 0.82 MAOA (0.41) KDM4EALDH1A1
SCHEMBL19067831 0.81 GABRA1 (0.42) GABRA1GABRB2MAPK1KDM4ECYP1A2
SCHEMBL8309858 0.81 TRIM24 (0.42) TRIM24TRIM33KDM4ECYP1A2ALDH1A1
SCHEMBL24025355 0.80 CYP1A2 (0.39) TRIM24TRIM33KDM4ECYP1A2ALDH1A1
Benzene SCHEMBL11824212 0.79 TRIM24 (0.37) GABRA1GABRB2TRIM24TRIM33KDM4E
SCHEMBL4035579 0.78 TRPA1 (0.42) CYP2C9SLC6A2
SCHEMBL4032446 0.78 NFE2L2 (0.36) ALDH1A1
SCHEMBL4229224 0.78 HTT (0.45) TRIM24TRIM33KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613613-B1 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS GENZYME CORP (US) 2021-06-02 EP disclosed
US-7863293-B2 CXCR4 chemokine receptor binding compounds GENZYME CORPORATION (US) 2011-01-04 US disclosed
EP-1613613-A4 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC (CA) 2009-03-25 EP disclosed
US-20080255197-A1 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED CORPORATION (CA) 2008-10-16 US disclosed
US-7291631-B2 CXCR4 chemokine receptor binding compounds GENZYME CORPORATION (US) 2007-11-06 US disclosed
EP-1613613-A2 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC. (CA) 2006-01-11 EP disclosed
WO-2004091518-A2 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC. (CA) 2004-10-28 WO disclosed
US-20040209921-A1 CXCR4 chemokine receptor binding comounds ANORMED CORPORATION (CA) 2004-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040209921-A1 CXCR4 chemokine receptor binding comounds CXCR4, CXCR1, CXCR3 GABRA1 2491/4885GABRB2 2722/4885TRIM24 3247/4885
US-20080255197-A1 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS CXCR4, CXCR1, CXCR3 GABRA1 2225/4885GABRB2 2911/4885TRIM24 2478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.